姓名：康贵峰 性别：男 职称：讲师

2016年进入多肽及小分子药物北京市重点实验室，任药物化学系讲师。讲授课程包括药物化学、有机化学、药物的波谱解析实验、专业药学实验等。

教育经历

2005/8-2008/7，北京大学药学院，博士，导师：彭师奇、赵明。

2002/9-2005/7，中国科学院山西煤化所，硕士，导师：王建国。

1998/9-2002/7，西北大学化学系，学士。

工作经历

2016/1-至今，首都医科大学化学生物学院药学院，教师

2014/9-2015/12，美国弗吉尼亚联邦大学药物化学系，博士后

2012/4-2013/11，北京四环制药，项目经理

2009/12-2014/1，浙江大学、浙江医药股份有限公司新昌制药厂联合培养，博士后

2009/12-2012/3，浙江医药股份有限公司新昌制药厂，职工

2008/9-2009/10，康龙化成（北京）新药技术有限公司，高级研究员

药物化学，有机化学杂环小分子的设计、合成、活性评价及作用机制研究

1.GuifengKang,YujiWang,JiawangLiu,JianhuiWu,MingZhao,GuochunLi,NingLi,LiPeng,XiaoyiZhang,LiLi,NathanMair,ShiqiPeng,Developmentofthree-componentconjugates:togetnano-globeswithpououssurfaces,highinvivoanti-osteoporosisactivityandminimalsideeffects,J.Mater.Chem.,09/2012,22(40),21740-21748.

2.GuifengKang,MingZhao,XiaoyiZhang,LiPeng,ChunboLi,WeiMao,WeidongYe,ShiqiPeng“AclassofnovelconjugatesofsubstitutedpurineandGly-AA-OBzl:Synthesisandevaluationoforallyanalgesicactivity”,Bioorg.Med.Chem.Lett.,10/2010,20(20),6157-6160.

3.YujiWang,GuifengKang,JiawangLiu,MingZhao,JianhuiWu,XiaoyiZhang,YeLi,XiaoboZhong,YifanYang,ShiqiPeng,NovelpotassiumN-[(2S,3R,4R,5R)-2,3,4,5,6-pentahy-droxylhex-1-yl]-L-aminoaciddichloroplatinates(II)withhighanti-tumoractivityandlowsidereaction,Metallomics,04/2012,4(5),441-447.

4.JinghuaZhao,GuifengKang,WeiWang,MingZhao,XiaoyiZhang,ChunboLu,WeiMao,HengWeiChang,WeidongYe,ShiqiPeng,N-[2-Chloro-9H-purin-6-yl]-N-cyclopropylgly-cylaminoacidsandderivatives:Synthesis,evaluationasaclassofnovelanalgesics,and3DQSARanalysis,Bioorg.Med.Chem.,08/2009,17(17),6305-6310.

5.YujiWang,GuifengKang,MingZhao,JianhuiWu,XiaoyiZhang,YifanYang,JiawangLiu,ShiqiPeng,Anewplatinum-complexshoweasypreparation,promisinganti-tumoractivity,andbetterefficacyanddistributionpropertiesthanoxaliplatin,Mol.BioSyst.,12/2011,7(12),3245-3252.

6.NingLi,GuifengKang,LinGui,MingZhao,WenjingWang,JianweiZhang,Yan-FengYue,ShiqiPeng,NovelCu(II)-RGD-octapeptides:Synthesis,coordinationmode,invitroanti-plateletaggregation/invivoanti-thromboticevaluationandcorrelationofsequencewithnano-structure.,Nanomed-Nanotechnol.,01/2011,7(4),403-409.

7.YujiWang,JianhuiWu,GuifengKang,MingZhao,LinGui,NingLi,LiPeng,XiaoyiZhang,LiLi,ShiqiPeng,Novelnano-materialsRGD-tetrapeptide-modified17β-amino-11α-hydroxyandrost-1,4-diene-3-one:synthesis,self-assemblybasednano-imagesandinvivoanti-osteoporosisevaluation,J.Mater.Chem.,02/2012,22(11),4652-4659.

8.YujiWang,JianhuiWu,GuifengKang,MingZhao,LinGui,NingLi,LiPeng,XiaoyiZhang,LiLi,ShiqiPeng,Novelnano-materialsRGD-tetrapeptide-modified17β-amino-11α-hydroxyandrost-1,4-diene-3-one:synthesis,self-assemblybasednano-imagesandinvivoanti-osteoporosisevaluation,J.Mater.Chem.,02/2012,22(11),4652-4659.

9.JingchengTang,MingZhao,YujiWang,GuifengKang,JianhuiWu,MeiqingZheng,ShiqiPeng,OnesingleHPLC-PDA/(-)ESI-MS/MSanalysistosimultaneouslydetermine30componentsoftheaqueousextractofRabdosiarubescens,J.Chromatogr.B.,09/2011,879(26)2783-2793.

10.JianhuiWu,LeiWei,MingZhao,YujiWang,GuifengKang,ShiqiPeng,N-[2(3-Carboxyl-9-benzyl-carboline-1-yl)ethyl-1-yl]-aminoacids:correlationofspectralpropertywithinvivoanti-tumoractivity,Med.Chem.Res.,04/2012,21(1),116-123.

11.WenjingWang,MingZhao,YujiWang,JiawangLiu,JianhuiWu,GuifengKangandShiqiPeng,{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-aceticacidmethylester(MIAM):Itsanti-cancerefficacyandintercalationmechanismidentifiedviamulti-modelsystems,Mol.BioSyst.,03/2011,7(3),766-772.